Dysphasia as a novel approach for classification of speech disorders in Parkinson’s disease and other forms of neurodegeneration
Objective: To classify and identify the features of speech disorders in Parkinson's disease and other neurodegenerative diseases. Background: No unified approach to classification and diagnostics…The interaction of Parkin and TAF15 for the Drosophila in which neuronal defect was induced
Objective: Our study proposes a novel regulator for the protection of TAF15-induced proteinopathy and adds to our understanding of the exact pathogenic mechanism for TAF15-induced…Pulmonary function in Parkinson’s disease
Objective: To establish if pulmonary function is impaired in Parkinson’s disease (PD) and define any pattern of impairment. Background: Parkinson’s disease (PD) is associated with…Impulse Control Disorders and Other Psychiatric Complications in a Series of Patients Treated Levodopa-Carbidopa Instestinal Gel
Objective: To determine the frequency of ICDs and other psychiatric complications in a serie of patients of the Movement Disorders Unit of our center, treated…Psychiatric comorbidities in Young Onset Parkinson’s disease
Objective: The study aims at exploring psychiatric comorbities;namely;anxiety,depression and impulse control disorders(ICD) and their inter relationship in a large cohort of Young onset PD(YOPD)patients. Background:…Population pharmacokinetic analysis of levodopa and carbidopa after subcutaneous administration with and without adjunct oral therapy
Objective: To develop population pharmacokinetic (PK) models for levodopa (LD) and carbidopa (CD) following subcutaneous (SC) infusion, including adjunct oral LD/CD administration. Background: ND0612 is…A Long-Term Safety, Tolerability, and Efficacy Study of Apomorphine Sublingual Film for On-Demand Treatment of “OFF” Episodes in Patients With Parkinson’s Disease: Interim Results
Objective: Evaluate the long-term safety (LTS), tolerability, and efficacy of apomorphine sublingual film (APL-130277; APL) for on-demand treatment of “OFF” episodes in patients with Parkinson’s…The exosomal a-syn filaments can be a novel biomarker of Parkinson’s disease
Objective: This study is aimed to investigate whether the number of exosomes, the amount of total or exosomal a-synuclein (a-syn) filaments in serum can serve as…Pharmacokinetics and Biomarker Changes in NILO-PD, A Phase 2A Study of Nilotinib in Patients with Moderate to Advanced Parkinson’s Disease
Objective: To assess serum pharmacokinetics (PK) and cerebrospinal fluid (CSF) concentrations of nilotinib as well as CSF biomarker changes in NILO-PD study. Background: Several cell…Types of Pain in Parkinson`s Disease Patients
Objective: To present the characteristics of four different types of pain in Parkinson`s disease (PD) patients. Background: Neurodegeneration can cause a nociceptive disturbances at many…
- « Previous Page
- 1
- …
- 41
- 42
- 43
- 44
- 45
- …
- 149
- Next Page »